Systemic lupus erythematosus (SLE)
Ashira Blazer, MD;MS
University of Maryland Baltimore
Baltimore, Maryland, United States
Disclosure information not submitted.
Amit Saxena, MD;MSc
NYU School of Medicine
New York, New York, United States
Disclosure(s): AbbVie: Advisor or Review Panel Member (Terminated, March 15, 2023); AstraZeneca: Advisor or Review Panel Member (Ongoing); Aurinia: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Dinner (Terminated, November 11, 2023); GSK: Advisor or Review Panel Member (Terminated, March 16, 2022); Synthekine: Consultant (Ongoing)
Lupus nephritis is a common, yet potentially severe complication of systemic lupus erythematosus. Despite a renaissance in lupus treatments, the standards for diagnosis and treatment are still challenging for many rheumatologists. This session will use case-based questions to guide attendees through the pearls of managing lupus nephritis.
Speaker: Maria Dall'Era, MD – UCSF